Fact CheckerSign in

NCT03514602Recruiting

Maternal Smoking Cessation and Pediatric Obesity Prevention

Pilot Study on Pediatric Obesity Prevention by Maternal Smoking Cessation in Pregnancy and Lactation

Source: ClinicalTrials.gov · Last updated 30 Jul 2026

Brief summary (registry, in English)

The objective of this study is to test the effect of smoking cessation in pregnancy or in lactation on preventing rapid infant adiposity gain. Investigators propose a randomized, controlled experiment among smoking pregnant women from 1st prenatal care visit through 6 months of postpartum period. Two-phase randomization will be applied to separate the effects of smoking cessation in two different critical periods (i.e., pregnancy and lactation) on infant adiposity gain. Investigators will first randomly assign 40 smoking pregnant women into either the multicomponent intervention (N=30) or the education-only control group (N=10). The multicomponent intervention group will receive education and counseling, monitoring and feedback, contingent financial incentives, and family support, while the control group will receive education only. At the end of pregnancy, investigators will further randomize successful quitters (estimated N=20) from the multi-component intervention group into either the continuous multi-component intervention group in lactation (N=10) or the education-only control group (N=10). All women and their newborns will be followed from enrollment to 6 months postpartum. The key outcomes include maternal smoking abstinence confirmed by urine-cotinine and infant gain in weight-for-length z-score. Specific Aim 1 is to examine the effects of maternal smoking cessation intervention in pregnancy on infant gain in weight-for-length z-score from birth to 6 months. Specific Aim 2 is to examine the effect of maternal smoking abstinence intervention in lactation and infant post-weaning gain in weight-for-length z-score among the women who have successfully quit smoking in pregnancy.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
48 (estimated)
First submitted
22 Jan 2018
Start date
1 Jul 2015
Primary completion date
31 Dec 2027
Lead sponsor
State University of New York at Buffalo
Diseases
Obesity
NCT number
NCT03514602

What you commit to

  • Study type: Interventional
  • Planned participants: 48
  • From 1 Jul 2015 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous history of major chronic disease or blood clotting disorders such as cancer, thyroid disorders, heart disease, kidney disease

Other illness

  • In treatment for Axis 1 disorders that prevent them following smoking cessation interventions

Other

  • Depression or have been diagnosed with depression or post-partum depression at any time

Who the study is looking for

  • Able to read, understand, and speak English.
  • Are 18-39 years old
  • Are less than 20 weeks of gestation
  • Have a singleton pregnancy
  • Currently smoking one or more cigarettes per day, based on self-report.
  • Currently smoking biochemically verified by a level of 1 or higher in urine cotinine test (i.e., \>100ng/mL cotinine concentration).
  • Willing to try to quit or reduce smoking by behavioral intervention
  • Willing to monitor smoking status by breath carbon monoxide and saliva cotinine.
  • Willing to provide breath, saliva, and urine samples to test smoking status
  • With low household income (meeting federal income eligibility guidelines for the Special Supplemental Nutrition Program for Women, Infants, and Children) and/or low education level (≤12 years). These disadvantaged pregnant women are very likely not to quit spontaneously, and thus need extra intervention most.
  • Currently living in Erie County or Niagara County; don't plan to move out of these two counties during the current pregnancy.

Age in the registry: 18 years to 39 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Division of Behavioral Medicine Department of Pediatrics Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo
Coordinator of this site? Confirm its status
BuffaloUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.